Goette, Andreas <br/><br/>
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  12 2018 
 - 1936-1943 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/euy141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--adverse effects<br/>Atrial Fibrillation--diagnosis<br/>Cost Savings<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Echocardiography, Transesophageal<br/>Electric Countershock--adverse effects<br/>Emergency Service, Hospital<br/>Europe<br/>Factor Xa Inhibitors--adverse effects<br/>Female<br/>Hemorrhage--chemically induced<br/>Hospital Costs<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Readmission<br/>Patient Satisfaction<br/>Pyridines--adverse effects<br/>Risk Factors<br/>Thiazoles--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Warfarin--adverse effects